Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-06-09

AUTHORS

Chao-Wu Xiao, Amy Hendry

ABSTRACT

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and affects about 25% of the population globally. Obesity and diabetes are the main causes of the disease characterized by excessive accumulation of lipids in the liver. There is currently no direct pharmacological treatments for NAFLD. Dietary intervention and lifestyle modification are the key strategies in the prevention and treatment of the disease. Soy consumption is associated with many health benefits such as decreased incidence of coronary heart disease, type-2 diabetes, atherosclerosis and obesity. The hypolipidemic functions of soy components have been shown in both animal studies and human clinical trials. Dietary soy proteins and associated isoflavones suppressed the formation and accumulation of lipid droplets in the liver and improved NAFLD-associated metabolic syndrome. The molecular mechanism(s) underlying the effects of soy components are mainly through modulation of transcription factors, sterol regulatory element-binding protein-1 and peroxisome proliferator-activated receptor-γ2, and expressions of their target genes involved in lipogenesis and lipolysis as well as lipid droplet-promoting protein, fat-specific protein-27. Inclusion of appropriate amounts of soy protein and isoflavones in the diets might be a useful approach to decrease the prevalence of NAFLD and mitigate disease burden. More... »

PAGES

1-10

References to SciGraph publications

  • 2020-04-22. Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population in EUROPEAN JOURNAL OF EPIDEMIOLOGY
  • 2013-10-01. NAFLD, NASH and liver cancer in NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
  • 2013-11-30. Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats in GENES & NUTRITION
  • 2012-11-28. Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial in EUROPEAN JOURNAL OF CLINICAL NUTRITION
  • 2016-06-17. Single ingestion of soy β-conglycinin induces increased postprandial circulating FGF21 levels exerting beneficial health effects in SCIENTIFIC REPORTS
  • 2010-12-14. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism in INTERNATIONAL JOURNAL OF OBESITY
  • 2016-04-18. MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways in SCIENTIFIC REPORTS
  • 2012-04-24. Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors in GENES & NUTRITION
  • 2017-03-21. The α’ subunit of β-conglycinin and various glycinin subunits of soy are not required to modulate hepatic lipid metabolism in rats in EUROPEAN JOURNAL OF NUTRITION
  • 2013-11-26. The α′ subunit of β-conglycinin and the A1–5 subunits of glycinin are not essential for many hypolipidemic actions of dietary soy proteins in rats in EUROPEAN JOURNAL OF NUTRITION
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s11130-022-00984-1

    DOI

    http://dx.doi.org/10.1007/s11130-022-00984-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1148553927

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/35678936


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Food and Nutrition Science Program, Department of Chemistry, Carleton University, 1125 Colonel By Drive, K1S 5B6, Ottawa, ON, Canada", 
              "id": "http://www.grid.ac/institutes/grid.34428.39", 
              "name": [
                "Nutrition Research Division, Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, K1A 0L2, Ottawa, ON, Canada", 
                "Food and Nutrition Science Program, Department of Chemistry, Carleton University, 1125 Colonel By Drive, K1S 5B6, Ottawa, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Xiao", 
            "givenName": "Chao-Wu", 
            "id": "sg:person.0701237547.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701237547.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nutrition Research Division, Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, K1A 0L2, Ottawa, ON, Canada", 
              "id": "http://www.grid.ac/institutes/grid.57544.37", 
              "name": [
                "Nutrition Research Division, Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, K1A 0L2, Ottawa, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hendry", 
            "givenName": "Amy", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00394-017-1399-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084021389", 
              "https://doi.org/10.1007/s00394-017-1399-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ijo.2010.256", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022035867", 
              "https://doi.org/10.1038/ijo.2010.256"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrgastro.2013.183", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051442552", 
              "https://doi.org/10.1038/nrgastro.2013.183"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ejcn.2012.186", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026994264", 
              "https://doi.org/10.1038/ejcn.2012.186"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/srep23476", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026939217", 
              "https://doi.org/10.1038/srep23476"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10654-020-00627-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1126893906", 
              "https://doi.org/10.1007/s10654-020-00627-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00394-013-0620-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033937640", 
              "https://doi.org/10.1007/s00394-013-0620-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12263-013-0373-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031523637", 
              "https://doi.org/10.1007/s12263-013-0373-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12263-012-0294-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006088336", 
              "https://doi.org/10.1007/s12263-012-0294-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/srep28183", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002328031", 
              "https://doi.org/10.1038/srep28183"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2022-06-09", 
        "datePublishedReg": "2022-06-09", 
        "description": "Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and affects about 25% of the population globally. Obesity and diabetes are the main causes of the disease characterized by excessive accumulation of lipids in the liver. There is currently no direct pharmacological treatments for NAFLD. Dietary intervention and lifestyle modification are the key strategies in the prevention and treatment of the disease. Soy consumption is associated with many health benefits such as decreased incidence of coronary heart disease, type-2 diabetes, atherosclerosis and obesity. The hypolipidemic functions of soy components have been shown in both animal studies and human clinical trials. Dietary soy proteins and associated isoflavones suppressed the formation and accumulation of lipid droplets in the liver and improved NAFLD-associated metabolic syndrome. The molecular mechanism(s) underlying the effects of soy components are mainly through modulation of transcription factors, sterol regulatory element-binding protein-1 and peroxisome proliferator-activated receptor-\u03b32, and expressions of their target genes involved in lipogenesis and lipolysis as well as lipid droplet-promoting protein, fat-specific protein-27. Inclusion of appropriate amounts of soy protein and isoflavones in the diets might be a useful approach to decrease the prevalence of NAFLD and mitigate disease burden.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s11130-022-00984-1", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1097889", 
            "issn": [
              "0921-9668", 
              "1573-9104"
            ], 
            "name": "Plant Foods for Human Nutrition", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }
        ], 
        "keywords": [
          "non-alcoholic fatty liver disease", 
          "fatty liver disease", 
          "liver disease", 
          "prevalence of NAFLD", 
          "soy components", 
          "common chronic liver disease", 
          "chronic liver disease", 
          "coronary heart disease", 
          "type 2 diabetes", 
          "fat-specific protein 27", 
          "human clinical trials", 
          "sterol regulatory element-binding protein 1", 
          "regulatory element-binding protein 1", 
          "hypolipidemic functions", 
          "lifestyle modification", 
          "metabolic syndrome", 
          "dietary intervention", 
          "pharmacological treatment", 
          "soy consumption", 
          "dietary soy", 
          "hypolipidemic effects", 
          "heart disease", 
          "disease burden", 
          "clinical trials", 
          "animal studies", 
          "protein 27", 
          "disease", 
          "health benefits", 
          "protein 1", 
          "obesity", 
          "diabetes", 
          "lipid droplets", 
          "soy protein", 
          "excessive accumulation", 
          "liver", 
          "prevention", 
          "isoflavones", 
          "treatment", 
          "main cause", 
          "target genes", 
          "A Review", 
          "atherosclerosis", 
          "transcription factors", 
          "syndrome", 
          "prevalence", 
          "incidence", 
          "lipogenesis", 
          "trials", 
          "protein", 
          "lipolysis", 
          "intervention", 
          "diet", 
          "burden", 
          "key strategy", 
          "useful approach", 
          "cause", 
          "accumulation", 
          "effect", 
          "lipids", 
          "review", 
          "soy", 
          "population", 
          "expression", 
          "peroxisomes", 
          "modulation", 
          "factors", 
          "study", 
          "genes", 
          "benefits", 
          "function", 
          "inclusion", 
          "strategies", 
          "components", 
          "consumption", 
          "modification", 
          "appropriate amount", 
          "amount", 
          "formation", 
          "approach", 
          "droplets"
        ], 
        "name": "Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review", 
        "pagination": "1-10", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1148553927"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s11130-022-00984-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "35678936"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s11130-022-00984-1", 
          "https://app.dimensions.ai/details/publication/pub.1148553927"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T16:08", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_935.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s11130-022-00984-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11130-022-00984-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11130-022-00984-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11130-022-00984-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11130-022-00984-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    185 TRIPLES      21 PREDICATES      113 URIs      95 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s11130-022-00984-1 schema:about anzsrc-for:11
    2 anzsrc-for:1103
    3 schema:author N99c038079a354a17959d3ba3824910f4
    4 schema:citation sg:pub.10.1007/s00394-013-0620-9
    5 sg:pub.10.1007/s00394-017-1399-x
    6 sg:pub.10.1007/s10654-020-00627-2
    7 sg:pub.10.1007/s12263-012-0294-6
    8 sg:pub.10.1007/s12263-013-0373-3
    9 sg:pub.10.1038/ejcn.2012.186
    10 sg:pub.10.1038/ijo.2010.256
    11 sg:pub.10.1038/nrgastro.2013.183
    12 sg:pub.10.1038/srep23476
    13 sg:pub.10.1038/srep28183
    14 schema:datePublished 2022-06-09
    15 schema:datePublishedReg 2022-06-09
    16 schema:description Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and affects about 25% of the population globally. Obesity and diabetes are the main causes of the disease characterized by excessive accumulation of lipids in the liver. There is currently no direct pharmacological treatments for NAFLD. Dietary intervention and lifestyle modification are the key strategies in the prevention and treatment of the disease. Soy consumption is associated with many health benefits such as decreased incidence of coronary heart disease, type-2 diabetes, atherosclerosis and obesity. The hypolipidemic functions of soy components have been shown in both animal studies and human clinical trials. Dietary soy proteins and associated isoflavones suppressed the formation and accumulation of lipid droplets in the liver and improved NAFLD-associated metabolic syndrome. The molecular mechanism(s) underlying the effects of soy components are mainly through modulation of transcription factors, sterol regulatory element-binding protein-1 and peroxisome proliferator-activated receptor-γ2, and expressions of their target genes involved in lipogenesis and lipolysis as well as lipid droplet-promoting protein, fat-specific protein-27. Inclusion of appropriate amounts of soy protein and isoflavones in the diets might be a useful approach to decrease the prevalence of NAFLD and mitigate disease burden.
    17 schema:genre article
    18 schema:isAccessibleForFree true
    19 schema:isPartOf sg:journal.1097889
    20 schema:keywords A Review
    21 accumulation
    22 amount
    23 animal studies
    24 approach
    25 appropriate amount
    26 atherosclerosis
    27 benefits
    28 burden
    29 cause
    30 chronic liver disease
    31 clinical trials
    32 common chronic liver disease
    33 components
    34 consumption
    35 coronary heart disease
    36 diabetes
    37 diet
    38 dietary intervention
    39 dietary soy
    40 disease
    41 disease burden
    42 droplets
    43 effect
    44 excessive accumulation
    45 expression
    46 factors
    47 fat-specific protein 27
    48 fatty liver disease
    49 formation
    50 function
    51 genes
    52 health benefits
    53 heart disease
    54 human clinical trials
    55 hypolipidemic effects
    56 hypolipidemic functions
    57 incidence
    58 inclusion
    59 intervention
    60 isoflavones
    61 key strategy
    62 lifestyle modification
    63 lipid droplets
    64 lipids
    65 lipogenesis
    66 lipolysis
    67 liver
    68 liver disease
    69 main cause
    70 metabolic syndrome
    71 modification
    72 modulation
    73 non-alcoholic fatty liver disease
    74 obesity
    75 peroxisomes
    76 pharmacological treatment
    77 population
    78 prevalence
    79 prevalence of NAFLD
    80 prevention
    81 protein
    82 protein 1
    83 protein 27
    84 regulatory element-binding protein 1
    85 review
    86 soy
    87 soy components
    88 soy consumption
    89 soy protein
    90 sterol regulatory element-binding protein 1
    91 strategies
    92 study
    93 syndrome
    94 target genes
    95 transcription factors
    96 treatment
    97 trials
    98 type 2 diabetes
    99 useful approach
    100 schema:name Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review
    101 schema:pagination 1-10
    102 schema:productId Nd7933387ceb448ab86d9afd0e31f8c96
    103 Nd807744b2e354b058ed5e6ffa5e1a491
    104 Ne6efa84d175a4009b0c30a76a4847e0b
    105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1148553927
    106 https://doi.org/10.1007/s11130-022-00984-1
    107 schema:sdDatePublished 2022-09-02T16:08
    108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    109 schema:sdPublisher N618035ceecc24e52ad85a03e4a199c89
    110 schema:url https://doi.org/10.1007/s11130-022-00984-1
    111 sgo:license sg:explorer/license/
    112 sgo:sdDataset articles
    113 rdf:type schema:ScholarlyArticle
    114 N618035ceecc24e52ad85a03e4a199c89 schema:name Springer Nature - SN SciGraph project
    115 rdf:type schema:Organization
    116 N89bdd97a69f14e2c90dc9010ba9405ba rdf:first Nd0e9bc074595472cabb0cb217a7125de
    117 rdf:rest rdf:nil
    118 N99c038079a354a17959d3ba3824910f4 rdf:first sg:person.0701237547.06
    119 rdf:rest N89bdd97a69f14e2c90dc9010ba9405ba
    120 Nd0e9bc074595472cabb0cb217a7125de schema:affiliation grid-institutes:grid.57544.37
    121 schema:familyName Hendry
    122 schema:givenName Amy
    123 rdf:type schema:Person
    124 Nd7933387ceb448ab86d9afd0e31f8c96 schema:name pubmed_id
    125 schema:value 35678936
    126 rdf:type schema:PropertyValue
    127 Nd807744b2e354b058ed5e6ffa5e1a491 schema:name doi
    128 schema:value 10.1007/s11130-022-00984-1
    129 rdf:type schema:PropertyValue
    130 Ne6efa84d175a4009b0c30a76a4847e0b schema:name dimensions_id
    131 schema:value pub.1148553927
    132 rdf:type schema:PropertyValue
    133 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    134 schema:name Medical and Health Sciences
    135 rdf:type schema:DefinedTerm
    136 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    137 schema:name Clinical Sciences
    138 rdf:type schema:DefinedTerm
    139 sg:journal.1097889 schema:issn 0921-9668
    140 1573-9104
    141 schema:name Plant Foods for Human Nutrition
    142 schema:publisher Springer Nature
    143 rdf:type schema:Periodical
    144 sg:person.0701237547.06 schema:affiliation grid-institutes:grid.34428.39
    145 schema:familyName Xiao
    146 schema:givenName Chao-Wu
    147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701237547.06
    148 rdf:type schema:Person
    149 sg:pub.10.1007/s00394-013-0620-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033937640
    150 https://doi.org/10.1007/s00394-013-0620-9
    151 rdf:type schema:CreativeWork
    152 sg:pub.10.1007/s00394-017-1399-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1084021389
    153 https://doi.org/10.1007/s00394-017-1399-x
    154 rdf:type schema:CreativeWork
    155 sg:pub.10.1007/s10654-020-00627-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1126893906
    156 https://doi.org/10.1007/s10654-020-00627-2
    157 rdf:type schema:CreativeWork
    158 sg:pub.10.1007/s12263-012-0294-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006088336
    159 https://doi.org/10.1007/s12263-012-0294-6
    160 rdf:type schema:CreativeWork
    161 sg:pub.10.1007/s12263-013-0373-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031523637
    162 https://doi.org/10.1007/s12263-013-0373-3
    163 rdf:type schema:CreativeWork
    164 sg:pub.10.1038/ejcn.2012.186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026994264
    165 https://doi.org/10.1038/ejcn.2012.186
    166 rdf:type schema:CreativeWork
    167 sg:pub.10.1038/ijo.2010.256 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022035867
    168 https://doi.org/10.1038/ijo.2010.256
    169 rdf:type schema:CreativeWork
    170 sg:pub.10.1038/nrgastro.2013.183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051442552
    171 https://doi.org/10.1038/nrgastro.2013.183
    172 rdf:type schema:CreativeWork
    173 sg:pub.10.1038/srep23476 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026939217
    174 https://doi.org/10.1038/srep23476
    175 rdf:type schema:CreativeWork
    176 sg:pub.10.1038/srep28183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002328031
    177 https://doi.org/10.1038/srep28183
    178 rdf:type schema:CreativeWork
    179 grid-institutes:grid.34428.39 schema:alternateName Food and Nutrition Science Program, Department of Chemistry, Carleton University, 1125 Colonel By Drive, K1S 5B6, Ottawa, ON, Canada
    180 schema:name Food and Nutrition Science Program, Department of Chemistry, Carleton University, 1125 Colonel By Drive, K1S 5B6, Ottawa, ON, Canada
    181 Nutrition Research Division, Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, K1A 0L2, Ottawa, ON, Canada
    182 rdf:type schema:Organization
    183 grid-institutes:grid.57544.37 schema:alternateName Nutrition Research Division, Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, K1A 0L2, Ottawa, ON, Canada
    184 schema:name Nutrition Research Division, Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, K1A 0L2, Ottawa, ON, Canada
    185 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...